| Recurrent gain-of-function mutations of RHOA in diffuse-type gastric carcinoma M Kakiuchi, T Nishizawa, H Ueda, K Gotoh, A Tanaka, A Hayashi, ... Nature genetics 46 (6), 583-587, 2014 | 554 | 2014 |
| RHOA mutation in diffuse-type gastric cancer: a comparative clinicopathology analysis of 87 cases T Ushiku, S Ishikawa, M Kakiuchi, A Tanaka, H Katoh, H Aburatani, ... Gastric Cancer 19, 403-411, 2016 | 70 | 2016 |
| Frequent CLDN18-ARHGAP fusion in highly metastatic diffuse-type gastric cancer with relatively early onset A Tanaka, S Ishikawa, T Ushiku, S Yamazawa, H Katoh, A Hayashi, ... Oncotarget 9 (50), 29336, 2018 | 57 | 2018 |
| Use of droplet digital PCR for quantitative and automatic analysis of the HER2 status in breast cancer patients K Otsuji, T Sasaki, A Tanaka, A Kunita, M Ikemura, K Matsusaka, K Tada, ... Breast cancer research and treatment 162, 11-18, 2017 | 38 | 2017 |
| STAT1 as a potential prognosis marker for poor outcomes of early stage colorectal cancer with microsatellite instability A Tanaka, Y Zhou, M Ogawa, J Shia, DS Klimstra, JY Wang, MH Roehrl PLoS One 15 (4), e0229252, 2020 | 31 | 2020 |
| DEAD-box RNA helicase protein DDX21 as a prognosis marker for early stage colorectal cancer with microsatellite instability A Tanaka, JY Wang, J Shia, Y Zhou, M Ogawa, RC Hendrickson, ... Scientific reports 10 (1), 22085, 2020 | 22 | 2020 |
| Maspin as a prognostic marker for early stage colorectal cancer with microsatellite instability A Tanaka, JY Wang, J Shia, Y Zhou, M Ogawa, RC Hendrickson, ... Frontiers in Oncology 10, 945, 2020 | 19 | 2020 |
| EVI1 expression is associated with aggressive behavior in intrahepatic cholangiocarcinoma M Tanaka, J Shibahara, S Ishikawa, T Ushiku, T Morikawa, ... Virchows Archiv 474, 39-46, 2019 | 15 | 2019 |
| Prolyl 4-hydroxylase alpha 1 protein expression risk-stratifies early stage colorectal cancer A Tanaka, Y Zhou, J Shia, F Ginty, M Ogawa, DS Klimstra, ... Oncotarget 11 (8), 813, 2020 | 14 | 2020 |
| Tumor stromal nicotinamide N-methyltransferase overexpression as a prognostic biomarker for poor clinical outcome in early-stage colorectal cancer M Ogawa, A Tanaka, K Namba, J Shia, JY Wang, MHA Roehrl Scientific reports 12 (1), 2767, 2022 | 13 | 2022 |
| Early-stage loss of GALNT6 predicts poor clinical outcome in colorectal cancer M Ogawa, A Tanaka, K Namba, J Shia, JY Wang, MH Roehrl Frontiers in Oncology 12, 802548, 2022 | 9 | 2022 |
| ABO blood group and risk of pancreatic carcinogenesis in intraductal papillary mucinous neoplasms T Hamada, H Oyama, Y Nakai, M Tada, H Koh, K Tateishi, J Arita, ... Cancer Epidemiology, Biomarkers & Prevention 30 (5), 1020-1028, 2021 | 9 | 2021 |
| Proteogenomic characterization of primary colorectal cancer and metastatic progression identifies proteome-based subtypes and signatures A Tanaka, M Ogawa, Y Zhou, K Namba, RC Hendrickson, MM Miele, Z Li, ... Cell Reports 43 (2), 2024 | 6 | 2024 |
| Pancreatoblastomas and mixed and pure acinar cell carcinomas share epigenetic signatures distinct from other neoplasms of the pancreas JK Benhamida, M Vyas, A Tanaka, L Wang, A Bahrami, K Ozcan, ... Modern Pathology 35 (7), 956-961, 2022 | 3 | 2022 |
| Heart failure complicated by alveolar hemorrhage due to vascular collapse and amyloid deposits in wild-type transthyretin amyloidosis Y Kido, M Takahashi, N Fukuma, T Kawata, A Tanaka, A Hayashi, ... Cardiology 135 (4), 216-220, 2016 | 3 | 2016 |
| Propensity score matching as an effective strategy for biomarker cohort design and omics data analysis M Maekawa, A Tanaka, M Ogawa, MH Roehrl Plos one 19 (5), e0302109, 2024 | 1 | 2024 |
| The role of C1orf50 in breast cancer progression and prognosis Y Otani, A Tanaka, M Maekawa, T Peña, A Rogachevskaya, T Ando, ... Breast Cancer, 1-14, 2024 | | 2024 |
| Proteomic basis for pancreatic acinar cell carcinoma and pancreatoblastoma as similar yet distinct entities A Tanaka, M Ogawa, Y Zhou, RC Hendrickson, MM Miele, Z Li, ... NPJ Precision Oncology 8 (1), 221, 2024 | | 2024 |
| Proteogenomic characterization of pancreatic neuroendocrine tumors uncovers hypoxia and immune signatures in clinically aggressive subtypes A Tanaka, M Ogawa, Y Zhou, Y Otani, RC Hendrickson, MM Miele, Z Li, ... iScience 27 (8), 2024 | | 2024 |
| Protein expression of the amino acid transporter SLC7A5 in tumor tissue is prognostic in early-stage colorectal cancer M Ogawa, A Tanaka, M Maekawa, K Namba, Y Otani, J Shia, JY Wang, ... Plos one 19 (5), e0298362, 2024 | | 2024 |
Michael H. A. RoehrlBeth Israel Deaconess Medical Center, Harvard Medical School在 bidmc.harvard.edu 的电子邮件经过验证
